5-[4-[(dimethylamino)methyl]phenyl]-1-methyl-6-(1-phenylethylsulfanyl)pyrazolo[5,4-d]pyrimidin-4-one
C23H25N5OS — CID 164619896
Data last refreshed: (MolForge compound catalog, from PubChem)
About 5-[4-[(dimethylamino)methyl]phenyl]-1-methyl-6-(1-phenylethylsulfanyl)pyrazolo[5,4-d]pyrimidin-4-one
5-[4-[(dimethylamino)methyl]phenyl]-1-methyl-6-(1-phenylethylsulfanyl)pyrazolo[5,4-d]pyrimidin-4-one (PubChem CID 164619896) has the molecular formula C23H25N5OS and a molecular weight of 419.55 g/mol. Its IUPAC name is 5-[4-[(dimethylamino)methyl]phenyl]-1-methyl-6-(1-phenylethylsulfanyl)pyrazolo[5,4-d]pyrimidin-4-one.
Molecular Properties
| Compound Name | 5-[4-[(dimethylamino)methyl]phenyl]-1-methyl-6-(1-phenylethylsulfanyl)pyrazolo[5,4-d]pyrimidin-4-one |
|---|---|
| PubChem CID | 164619896 |
| Molecular Formula | C23H25N5OS |
| Molecular Weight | 419.55 g/mol |
| Exact Mass | 419.18 |
| IUPAC Name | 5-[4-[(dimethylamino)methyl]phenyl]-1-methyl-6-(1-phenylethylsulfanyl)pyrazolo[5,4-d]pyrimidin-4-one |
| SMILES | CC(Sc1nc2c(cnn2C)c(=O)n1-c1ccc(CN(C)C)cc1)c1ccccc1 |
| InChI | InChI=1S/C23H25N5OS/c1-16(18-8-6-5-7-9-18)30-23-25-21-20(14-24-27(21)4)22(29)28(23)19-12-10-17(11-13-19)15-26(2)3/h5-14,16H,15H2,1-4H3 |
| InChIKey | WIQXOGXDHADXSI-UHFFFAOYSA-N |
| XLogP | 4.03 |
| TPSA | 55.95 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 30 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 419.55 |
| LogP ≤ 5 | 4.03 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 164619896 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.